Solid Malignancies clinical trials at UCSF
1 research study open to eligible people
Solid malignancies are cancers that form in solid organs or tissues. UCSF is studying a new drug called AZD9574 alone and with other cancer drugs to see if it is safe and how it works in the body. These trials are for people with advanced solid tumors.
Showing trials for
AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
open to eligible people ages 18-130
This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer agents in 490 participants with advanced cancer that has recurred/progressed.
San Francisco, California and other locations
Last updated: